 |
 |

Registering Clinical Trials
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: Drs Dickersin and Rennie1 stated that a comprehensive register of clinical trials would address the problem of publication bias. However, they omitted an important aspect of this problem. Every researcher has had the experience of a manuscript being rejected. This sometimes occurs with well-designed and well-executed studies with good data simply because the results were not considered to be newsworthy by journal editors. Although this is a hazard of academic medicine, it nevertheless should be noted that journals as well as researchers are responsible for publication bias. Therefore, if a future researcher or patient looking in a registry finds a clinical trial that otherwise seemed to have disappeared, the results may have been very important and close to the researcher's heart, but not to an editorial board of a medical journal.
Unless the outcomes of such studies were made part of the registry, it would be impossible . . . [Full Text of this Article]
Ira Leviton, MD
Division of Infectious Diseases Montefiore Hospital and the Albert Einstein College of Medicine Bronx, NY
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLES
Registering Clinical Trials
Giovanni Della Cioppa and Jean-Jacques Garaud
JAMA. 2003;290(19):2545-2546.
EXTRACT
| FULL TEXT
Registering Clinical TrialsReply
Kay Dickersin and Drummond Rennie
JAMA. 2003;290(19):2546.
EXTRACT
| FULL TEXT
Registering Clinical Trials
Kay Dickersin and Drummond Rennie
JAMA. 2003;290(4):516-523.
ABSTRACT
| FULL TEXT
|